Event Announcement: MACRAMÉ will hold it’s Final Dissemination Event (ONLINE)
The MACRAMÉ FInal Dissemination Event (ONLINE) will take place 6th May 2026 10:00 – 15:00 CEST – safe the date!
The MACRAMÉ FInal Dissemination Event (ONLINE) will take place 6th May 2026 10:00 – 15:00 CEST – safe the date!
The ‘Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials’ hosted at the Organisation for Economic Cooperation and Development (OECD) in Paris and co-organised by four Horizon Europe projects ACCORDs, iCARE, MACRAMÉ, and nanoPASS, was a full success. Now, the full report of the event is available.
Continuing the NanoHarmony NANOMET journey: Harmonisation & Standardisation of Test Methodsfor Nanomaterials and Advanced Materials– Where did our research projects get us, and where do we go from here? *** ONLINE *** 3rd & 4th November 2025 The Horizon Europe projects MACRAMÉ, iCARE, nanoPASS and DESIDERATA invite you to an exclusive Read more
MACRAMÉ Experts used the opportunity to provide feedback in the commenting phase of the revision of the Safe and Sustainable by Design Chemicals and Materials Framework.
The MACRAMÉ Project team has published an Innovation Report about its Project’s R&I approach. In the paper entitled ‘MACRAMÉ – Advanced characterisation methodologies to assess and predict the health and environmental risks of advanced materials‘, the authors describe the planned information-flow between the different R&I activities conducted in the Project (see Read more
The MACRAMÉ Project was invited to give evidence to the 5th Stakeholder Workshop on ‘Safe & Sustainable by Design’, hosted by the European Commission on the 5. and 6. December 2024 in Brussels. Based on the feedback that the MACRAMÉ Project had provided during the second testing period, the Project Read more
MACRAMÉ Partner EMPA published a paper with the title ‘Bridging the gap: Innovative human-based in vitro approaches for nanomaterials hazard assessment and their role in safe and sustainable by design, risk assessment, and life cycle assessment’. The application of nanomaterials in industry and consumer products is growing exponentially, which has pressed the development and use of predictive human in vitro models in pre-clinical analysis to closely extrapolate potential toxic effects in vivo.
MACRAMÉ Coordinator, Dr Steffi Friedrichs, presented the project’s interim results at the NanoTox 2024 conference, held 23. to 25. September in Venice (Italy). In a presentation entitled ‘Interim Results of the MACRAMÉ R&I Approach – Ensuring regulatory Alignment in the Research & Innovation of five market-relevant Advanced Materials’, Dr Friedrichs Read more
RIVM works towards a healthy population in a sustainable, safe and healthy living environment. To that end, we are a trusted advisor to the government, professionals and private citizens. Within the MACRAMÉ project, RIVM contributes to benchmarking and demonstration of cell-line-based in vitro assays for initial screening of inhalable materials. Read more
In its Report on Stakeholder Involvement & Knowledge Transfer in the first 18 Months, the MACRAMÉ Project provides an overview of the stakeholder engagement and knowledge transfer on harmonisation and standardisation (H&S) activities for advanced materials undertaken in the first 18 months. The Project organised and conducted a number of Read more